
WHEN Joy Milne’s husband Les started to give off a strange musky scent, she was none too happy. She has always had a keen sense of smell, and this was unmissable. “It was almost like a slap in the face,” she says. “I didn’t like it.”
Les was adamant he was looking after himself properly, and when no one else picked up on the smell, Joy let the matter lie. It was only 12 years later, when Les was diagnosed with ʲ쾱ԲDz’s disease, that she realised the magnitude of what she had noticed.
Joy, who lives in Perth, UK, is a super-smeller with an almost supernatural ability to sense odours that most people don’t perceive. Perhaps this is because she experiences synaesthesia, a neurological condition in which different kinds of sensory information become mixed-up. That means she can visualise the flow of smells and even experience them as sensations. “Some smells make my back go cold,” she says. She has to avoid the supermarket aisle with soaps and make-up because it is too overpowering.
Advertisement
In the same way that a wine taster might train their nose to recognise the different aromas of the drink, she thinks that her work as a nurse attuned her sense of smell to different medical conditions. Now, retired after decades of vivid olfaction, her incredible nose is helping find new ways to diagnose diseases.
This unusual career path has its origins in 1994, when Les was diagnosed with ʲ쾱ԲDz’s disease aged only 45. This condition destroys dopamine-producing cells in the brain, leading to tremors and difficulty moving.
When the couple went to a support group for people with ʲ쾱ԲDz’s, Joy noticed something strange: Les wasn’t the only one with the greasy smell. Everyone else with ʲ쾱ԲDz’s seemed to have it too. Under the pretext of handing out cups of tea, Joy took a few good sniffs to confirm her suspicions. She became convinced that the condition has a unique smell – the one that she had noticed on Les more than a decade earlier. “I was smelling ʲ쾱ԲDz’s in the whole room,” she says.
But as far as Les and Joy were aware, ʲ쾱ԲDz’s wasn’t known to have a distinctive odour. So when Joy met neurobiologist Tilo Kunath, who studies the condition at the University of Edinburgh, UK, she asked him about it. Kunath said there was nothing in the literature about a particular ʲ쾱ԲDz’s smell.
Kunath thought nothing more about Joy’s questions until a colleague suggested that her observation might be worth investigating. After all, cancer has an odour that can be detected by specially trained dogs. Why not other diseases too?
So Kunath got back in touch with Joy, and their conversation convinced him that she was on to something. He decided to put her skills to the test. She was given identical T-shirts to smell, and asked to determine which had been worn by people with ʲ쾱ԲDz’s. She passed with flying colours – with one exception, where she identified one of the people who hadn’t been diagnosed with ʲ쾱ԲDz’s as having the disease.
Eight months later, the person Joy misidentified told Kunath he had been diagnosed with ʲ쾱ԲDz’s. “When this false-positive turned out to be a true positive, that was a jaw-dropping moment. We couldn’t believe it,” says Kunath. “Joy was telling us this person had ʲ쾱ԲDz’s before anyone knew.” It seemed like Joy really did have the ability to sniff out the condition before the neurological symptoms arise.
That was potentially enormous news. As a rule, ʲ쾱ԲDz’s is diagnosed via symptoms such as tremors or movement difficulties, by which time irreversible brain damage has already occurred. “Fifty per cent of the neurons that make dopamine are usually lost by the time you get motor symptoms,” says Kunath. While no drugs presently exist to prevent or cure the condition, some promising treatments are in the . If and when these are approved, early diagnostic tests will be vital.
To find the chemicals responsible for the ʲ쾱ԲDz’s odour, Kunath teamed up with analytical chemist Perdita Barran at the University of Manchester, UK. “We want to find biomarkers that occur before the onset of the symptoms,” says Barran. The researchers soon secured funding from the charity ʲ쾱ԲDz’s UK as well as the Michael J. Fox foundation.
They started by listening to Joy. She had identified the upper back as the area of the body with a particularly strong smell, so the researchers took swabs of this region from people with ʲ쾱ԲDz’s and analysed the volatile compounds they found there.
“Alzheimer’s smells faintly of vanilla, whereas cancer has an earthy, vegetable smell”
The preliminary results are promising. In November 2018, the team reported a number of biomarkers that seemed to differ between people who did and didn’t have the condition. “There is a signature that looks significantly enriched in ʲ쾱ԲDz’s patients,” says Kunath.
The real challenge, however, is to see whether this chemical signature can be detected on people who unknowingly have the condition but who currently show no symptoms, such as those with REM sleep disorders who have a high chance of developing ʲ쾱ԲDz’s. The aim is to have a diagnostic test ready for when drugs to treat the condition become available.
Passing the smell test
Joy is involved in this research too – sniffing the compounds isolated from swab samples to evaluate whether they match the ʲ쾱ԲDz’s smell that she first identified on her husband.
But for Joy, ʲ쾱ԲDz’s is just the beginning. “Almost every disease has a unique odour,” she says. To her, Alzheimer’s smells faintly of vanilla, whereas cancer has an earthy, vegetable smell. So her remarkable abilities could allow for early detection of other diseases, too.
Last year, she visited Tanzania to help the charity APOPO, which trains African giant pouched rats to detect tuberculosis – another disease that is hard to diagnose but which, for Joy, has a particularly harsh smell. In Tanzania, she observed the rats smelling saliva samples from children with TB, giving pointers on the protocol and background scents in the working environment.
“Joy can tell us things in a day, whereas a rat would take months,” says APOPO’s CEO Christophe Cox. “She could really speed up our work.” Plans are afoot, too, for a project to diagnose TB from its smell, combining Joy’s olfactory talent with the analytical skills of Barran’s team in Manchester.
Joy is excited about her new career as a super-smeller, given its potential to help people identify and treat devastating conditions in their early stages. She finds solace in knowing that the breakthroughs her work might enable could give people like Les, who passed away in 2015, a better chance. “It isn’t an easy thing to do, to sniff a disease. But it’s hard to watch the person you love being destroyed by something that no one can do anything about and I don’t want other families to suffer the way our family suffered,” she says. “We humans have turned our back on our sense of smell. We should be using it more.”
Kunath agrees. “We might just be touching the tip of the iceberg regarding what can be detected with odour.”